Tootfinder

FDA approves pancreatic cancer drug that extends patients’ lives
The Food and Drug Administration has approved a new pancreatic cancer drug,
a pill that nearly doubled patients’ average survival times
for one of the deadliest cancers
when taken instead of chemotherapy.

Researchers have called the drug,
known as #Rasonque or

FDA approves pancreatic cancer drug that extends patients’ lives
In trials, Revolution Medicines’ daraxonrasib nearly doubled average survival times for one of the deadliest cancers.